|
1
|
Marshall GM, Carter DR, Cheung BB, Liu T,
Mateos MK, Meyerowitz JG and Weiss WA: The prenatal origins of
cancer. Nat Rev Cancer. 14:277–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rich JN and Bigner DD: Development of
novel targeted therapies in the treatment of malignant glioma. Nat
Rev Drug Discov. 3:430–446. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vandewalle J, Luypaert A, De Bosscher K
and Libert C: Therapeutic mechanisms of glucocorticoids. Trends
Endocrinol Metab. 29:42–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Funakoshi Y, Shiono H, Inoue M, Kadota Y,
Ohta M, Matsuda H, Okumura M and Eimoto T: Glucocorticoids induce
G1 cell cycle arrest in human neoplastic thymic epithelial cells. J
Cancer Res Clin Oncol. 131:314–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cabrelle A, Maschio N, Carraro S, Frezzato
F, Binotto G, Gattazzo C, Miorin M, Agostini C, Zambello R,
Pandolfi F, et al: Apoptotic effect of cyclosporin a and
dexamethasone in malignant cells of patients with B-chronic
lymphocytic leukemia. J Biol Regul Homeost Agents. 23:239–250.
2009.PubMed/NCBI
|
|
7
|
Bucak YY, Erdurmus M, Terzi EH, Kükner A
and Celebi S: Inhibitory effects of topical cyclosporine A 0.05% on
immune-mediated corneal neovascularization in rabbits. Graefes Arch
Clin Exp Ophthalmol. 251:2555–2561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smolej L, Doubek M, Panovská A, Simkovič
M, Brychtová Y, Belada D, Motyčková M and Mayer J: Rituximab in
combination with high-dose dexamethasone for the treatment of
relapsed/refractory chronic lymphocytic leukemia. Leuk Res.
36:1278–1282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Šimkovič M, Motyčková M, Belada D, Vodárek
P, Kapoor R, Jaffar H, Vrbacký F, Žák P and Smolej L: Five years of
experience with rituximab plus high-dose dexamethasone for
relapsed/refractory chronic lymphocytic leukemia. Arch Med Sci.
12:421–427. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fuse H, Nozaki T, Fujiuchi Y, Mizuno I,
Nagakawa O and Okumura A: Treatment with prednisolone of
hormone-refractory prostate cancer. Arch Androl. 52:35–38. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miura N, Numata K, Kusuhara Y, Shirato A,
Hashine K and Sumiyoshi Y: Docetaxel-prednisolone combination
therapy for Japanese patients with hormone-refractory prostate
cancer: A single institution experience. Jpn J Clin Oncol.
40:1092–1098. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ladoire S, Eymard JC, Zanetta S, Mignot G,
Martin E, Kermarrec I, Mourey E, Michel F, Cormier L and
Ghiringhelli F: Metronomic oral cyclophosphamide prednisolone
chemotherapy is an effective treatment for metastatic
hormone-refractory prostate cancer after docetaxel failure.
Anticancer Res. 30:4317–4323. 2010.PubMed/NCBI
|
|
13
|
Juszczak GR and Stankiewicz AM:
Glucocorticoids, genes and brain function. Prog
Neuropsychopharmacol Biol Psychiatry. 82:136–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng J and Li L: The efficiency and safety
of dexamethasone for pain control in total joint arthroplasty: A
meta-analysis of randomized controlled trials. Medicine
(Baltimore). 96:e71262017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deen PM, Weghuis DO, Geurs van Kessel A,
Wieringa B and van Os CH: The human gene for water channel
aquaporin 1 (AQP1) is localized on chromosome 7p15->p14.
Cytogenet Cell Genet. 65:243–246. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boassa D, Stamer WD and Yool AJ: Ion
channel function of aquaporin-1 natively expressed in choroid
plexus. J Neurosci. 26:7811–7819. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen AL and Colman H: Glioma biology and
molecular markers. Cancer Treat Res. 163:15–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oshio K, Binder DK, Liang Y, Bollen A,
Feuerstein B, Berger MS and Manley GT: Expression of the
aquaporin-1 water channel in human glial tumors. Neurosurgery.
56:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saadoun S, Papadopoulos MC, Davies DC,
Bell BA and Krishna S: Increased aquaporin 1 water channel
expression in human brain tumours. Br J Cancer. 87:621–623. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deb P, Pal S, Dutta V, Boruah D, Chandran
VM and Bhatoe HS: Correlation of expression pattern of aquaporin-1
in primary central nervous system tumors with tumor type, grade,
proliferation, microvessel density, contrast-enhancement and
perilesional edema. J Cancer Res Ther. 8:571–577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
El Hindy N, Bankfalvi A, Herring A,
Adamzik M, Lambertz N, Zhu Y, Siffert W, Sure U and Sandalcioglu
IE: Correlation of aquaporin-1 water channel protein expression
with tumor angiogenesis in human astrocytoma. Anticancer Res.
33:609–613. 2013.
|
|
22
|
Liao ZQ, Ye M, Yu PG, Xiao C and Lin FY:
Glioma-associated oncogene homolog1 (Gli1)-Aquaporin1 pathway
promotes glioma cell metastasis. BMB Rep. 49:394–399. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peterson DL, Sheridan PJ and Brown WE Jr:
Animal models for brain tumors: Historical perspectives and future
directions. J Neurosurg. 80:865–876. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mattei TA, Ramina R, Miura FK, Aguiar PH
and Valiengo Lda C: Genetic therapy in gliomas: Historical analysis
and future perspectives. Neurol India. 53:17–26. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim SJ, Hwang E, Yi SS, Song KD, Lee HK,
Heo TH, Park SK, Jung YJ and Jun HS: Sea buckthorn leaf extract
inhibits glioma cell growth by reducing reactive oxygen species and
promoting apoptosis. Appl Biochem Biotechnol. 182:1663–1674. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Whittle IR, Macarthur DC, Malcolm GP, Li
M, Washington K and Ironside JW: Can experimental models of rodent
implantation glioma be improved? A study of pure and mixed glioma
cell line tumours. J Neurooncol. 36:231–242. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mead C and Pentreath VW: Evaluation of
toxicity indicators in rat primary astrocytes, C6 glioma and human
1321N1 astrocytoma cells: Can gliotoxicity be distinguished from
cytotoxicity? Arch Toxicol. 72:372–380. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kubota H, Fukuta K, Yamada K, Hirose M,
Naruyama H, Yanai Y, Yamada Y, Watase H, Kawai N, Tozawa K and
Yasui T: Feasibility of metronomic chemotherapy with
tegafur-uracil, cisplatin, and dexamethasone for
docetaxel-refractory prostate cancer. J Rural Med. 12:112–119.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong J, Tran LT, Lynch KA and Wood LJ:
Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy
and weight loss in female tumor free mice. Cancer Biol Ther.
19:87–96. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Branzei D and Foiani M: Regulation of DNA
repair throughout the cell cycle. Nat Rev Mol Cell Biol. 9:297–308.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiarugi A, Dölle C, Felici R and Ziegler
M: The NAD metabolome-a key determinant of cancer cell biology. Nat
Rev Cancer. 12:741–752. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eto I: Upstream molecular signaling
pathways of p27(Kip1) expression: Effects of 4-hydroxytamoxifen,
dexamethasone, and retinoic acids. Cancer Cell Int. 10:32010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang JK, Li CJ, Liao HJ, Wang CK, Wang GJ
and Ho ML: Anti-inflammatory drugs suppress proliferation and
induce apoptosis through altering expressions of cell cycle
regulators and pro-apoptotic factors in cultured human osteoblasts.
Toxicology. 258:148–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jing Y, Qian Y and Li ZJ: Sialylation
enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary
cells by dexamethasone. Biotechnol Bioeng. 107:488–496. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hayashi Y, Edwards NA, Proescholdt MA,
Oldfield EH and Merrill MJ: Regulation and function of aquaporin-1
in glioma cells. Neoplasia. 9:777–787. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moroz MA, Huang R, Kochetkov T, Shi W,
Thaler H, de Stanchina E, Gamez I, Ryan RP and Blasberg RG:
Comparison of corticotropin-releasing factor, dexamethasone, and
temozolomide: Treatment efficacy and toxicity in U87 and C6
intracranial gliomas. Clin Cancer Res. 17:3282–3292. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang
Y, Feng T, Wu J and Liu X: Sphingosine-1-phosphate induced
epithelial-mesenchymal transition of hepatocellular carcinoma via
an MMP-7/syndecan-1/TGF-β autocrine loop. Oncotarget.
7:63324–63337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zeng YE, Yao XH, Yan ZP, Liu JX and Liu
XH: Potential signaling pathway involved in
sphingosine-1-phosphate-induced epithelial-mesenchymal transition
in cancer. Oncol Lett. 12:379–382. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin YM, Jan HJ, Lee CC, Tao HY, Shih YL,
Wei HW and Lee HM: Dexamethasone reduced invasiveness of human
malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1)
dependent mechanism. Eur J Pharmacol. 593:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bauman GS, MacDonald W, Moore E, Ramsey
DA, Fisher BJ, Amberger VR and Del Maestro RM: Effects of radiation
on a model of malignant glioma invasion. J Neurooncol. 44:223–231.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marcus HJ, Carpenter KL, Price SJ and
Hutchinson PJ: In vivo assessment of high-grade glioma biochemistry
using microdialysis: A study of energy-related molecules, growth
factors and cytokines. J Neurooncol. 97:11–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Piette C, Deprez M, Roger T, Noël A,
Foidart JM and Munaut C: The dexamethasone-induced inhibition of
proliferation, migration, and invasion in glioma cell lines is
antagonized by macrophage migration inhibitory factor (MIF) and can
be enhanced by specific MIF inhibitors. J Biol Chem.
284:32483–32492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang D and Owler BK: Expression of AQP1
and AQP4 in paediatric brain tumours. J Clin Neurosci. 18:122–127.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zeng Y, Shen Y, Huang XL, Liu XJ and Liu
XH: Roles of mechanical force and CXCR1/CXCR2 in
shear-stress-induced endothelial cell migration. Eur Biophys J.
41:13–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Noell S, Fallier-Becker P, Mack AF,
Hoffmeister M, Beschorner R and Ritz R: Water channels aquaporin 4
and −1 expression in subependymoma depends on the localization of
the tumors. PLoS One. 10:e01313672015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
McCoy E and Sontheimer H: Expression and
function of water channels (aquaporins) in migrating malignant
astrocytes. Glia. 55:1034–1043. 2007. View Article : Google Scholar : PubMed/NCBI
|
